• Home
  • News
  • Kitbags
  • Contact
  • Diabetes Directory
  • Latest issue
  • Home
  • News
  • Kitbags
  • Contact
  • Diabetes Directory
  • Latest issue

GSK’s new T1 drug fails phase III clinical trial

30/03/2011 No Comments

GlaxoSmithKline says that Otelixizumab, a Type 1 drug currently under development, has failed in a phase III clinical trial. The drug has been in development

Read More »

Follow us elsewhere 

Facebook Twitter Instagram

Latest tweets

Recent posts

FDA clears Dexcom G7 CGM for 15-day wear

GLP-1s seen as key to managing T1D with obesity

Do sleep patterns affect glycaemic control?

  • Home
  • News
  • Kitbags
  • Contact
  • Diabetes Directory
  • Latest issue
  • Home
  • News
  • Kitbags
  • Contact
  • Diabetes Directory
  • Latest issue
Site by Loopmill